Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina.
Objectives. To evaluate implementation of the second round of human papillomavirus (HPV)-based cervical screening, introduced in Argentina in 2012--2014 through the Jujuy Demonstration Project for women 30 years and older, and describe the characteristics of women who adhere to the recommended five-...
| Publicado en: | Pan American Journal of Public Health Vol. 49; pp. 1 - 11 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artículo |
| Publicado: |
World Health Organization
2025
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=194015666&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 194015666 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 10204989 55OA jtl: Pan American Journal of Public Health issn: 10204989 maglogo: N pubinfo: dt: 2025 vid: 49 pid: 437 pub: World Health Organization artinfo: ui: 194015666 10.26633/RPSP.2025.92 ppf: 1 ppct: 10 formats: tig: atl: Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina. aug: au: Barbeira, Pilar Barcena Paolino, Melisa Binder, Fernando Almonte, Maribel Baena, Armando Mazzadi, Juan David Arrossi, Silvina affil: Centro de Estudios de Estado y Sociedad, Buenos Aires, Argentina Universidad de Buenos Aires, Buenos Aires, Argentina Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina University of Toronto, Toronto, Canada World Health Organization, Geneva, Switzerland International Agency for Research on Cancer, Lyon, France su: Argentina Medical screening Medical quality control Health policy Cervical cancer diagnosis Cervical cancer sug: subj: Medical screening Medical quality control Health policy Argentina Administration of Public Health Programs All Other Miscellaneous Ambulatory Health Care Services Cervical cancer diagnosis Cervical cancer keyword: human papillomavirus DNA tests implementation science mass screening Uterine cervical neoplasms ciencia de la implementación Neoplasias del cuello uterino pruebas de ADN del papillomavirus humano tamizaje masivo ciência da implementação Neoplasias do colo do útero programas de rastreamento testes de DNA para papilomavírus humano human papillomavirus DNA tests implementation science mass screening Uterine cervical neoplasms ciencia de la implementación Neoplasias del cuello uterino pruebas de ADN del papillomavirus humano tamizaje masivo ciência da implementação Neoplasias do colo do útero programas de rastreamento testes de DNA para papilomavírus humano ab: Objectives. To evaluate implementation of the second round of human papillomavirus (HPV)-based cervical screening, introduced in Argentina in 2012--2014 through the Jujuy Demonstration Project for women 30 years and older, and describe the characteristics of women who adhere to the recommended five-year rescreening interval. Methods. A retrospective cohort study was conducted based on the data of two rounds of screening. All women aged 30 years or older who had been HPV-tested during the Jujuy Demonstration Project and had a negative result were included. The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework was used to evaluate implementation. Multivariable regression was used to examine factors associated with adherence to rescreening. Results. Of 42 307 HPV-negative women, 47.9% (n = 20 285) were rescreened in the second round (Reach); 69.2% of health centers provided at least one HPV test at second-round screening (Adoption); and 13.3% (n = 5 639) of women were rescreened within the recommended five-year interval. Among the total rescreened, 9.3% (n = 1 888) were HPV-positive, of which 95.0% underwent triage Pap and 79.2% of the HPV-positive/ abnormal Pap women had colposcopy. Considering women rescreened at five years, the second-round detection rate was 5.3/1 000 screened women. Rescreening at five years was significantly higher among women aged 30--44, with public health insurance, and those living in the provincial capital. Conclusions. Rescreening of HPV-negative women faced challenges linked to its reduced reach, especially if we consider the recommended five-year interval. Our findings suggest that we need to devise specific strategies to increase second-round screening rates. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|